BPC-157 is a recognizable catalog name, but a research order needs more than the nickname and an mg figure. Begin with a sequence-level reference, identify the represented terminal form, and ask how that reference maps to the material offered. This prevents an apparently precise label from hiding an unresolved structural or quantity question.
Use a sequence reference, not a search snippet
The PubChem BPC-157 record gives GEPPPGKPADDAGLV and the condensed form H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH. That is a fifteen-residue sequence with an explicitly represented free N terminus and C-terminal acid. Use it as an identity reference, not as certification of a commercial vial. Save the record alongside the supplier’s proposed structure so the comparison has a traceable starting point.
Keep sequence and supplied form on separate lines
A sequence describes the residue order; a supplied-form statement adds information that the one-letter string does not carry. Ask whether the offer uses the same termini and stereochemistry, and request its salt or counterion description. Do not silently add acetate or another form because it appears in a nearby listing. The worksheet separates the database reference, supplier confirmation and batch evidence rather than treating them as one interchangeable source.
| Field | Reference or request | Required confirmation |
|---|---|---|
| Residue order | GEPPPGKPADDAGLV | Offered sequence matches the request |
| Termini | H–sequence–OH in the cited record | Actual offered terminal form |
| Supplied form | Salt / counterion description | No inferred default form |
| Quantity | mg basis plus container count | Declared versus measured amount |
| Evidence | Sample and lot reference | Report scope reviewed separately |
Resolve the meaning of the mg figure
Specify whether the quoted figure is nominal fill, total supplied solid mass or a stated peptide-content basis. These expressions are not automatically identical. Record container count separately and keep any analytical content result with its method and sample reference. Multiplying a label amount by vial count gives a declared order total; it does not independently measure delivered BPC-157. A high chromatography percentage should not be substituted for a missing quantity definition.
Choose evidence against the actual identity question
Ask which identity and purity records accompany the allocated material. A report should name the sample and connect it to the offered lot. If only an example report is available before allocation, retain that qualification. The laboratory reviewer should decide whether the analytical evidence addresses the needed distinctions; a familiar name on an MS screenshot is not the whole review. Structure, method scope and lot mapping should remain visible together.
Avoid importing biological claims into the order
Search results often combine material identity with statements about effects or clinical investigations. Those are separate questions and do not verify the material in this quotation. This guide does not establish approval, efficacy or suitability for human use. For procurement, finish with a written identity and quantity schedule, the outstanding questions and an assigned reviewer. An unresolved form should remain unresolved rather than being accepted because the product name is familiar.
Before closing this review
- Sequence order and termini are recorded.
- The offered chemical form is explicit.
- Nominal fill is not analytical content.
- The report is linked to the offered sample.
Continue with review the relevant catalog record; prepare a precise material inquiry. Save the relevant product or guide link alongside the written response so another reviewer can reconstruct the decision.
Editorial scope: research-material procurement and document review. Not medical guidance, dosing instructions or a claim of suitability for human use. Requirements and availability must be confirmed for the quoted material.
